Skip to content

The Objective of This Multicentre Study is to Collect Operative Data on the Related Clinical Functional Outcomes and Complications and of Market Approved Alcis Electrophysiology Catheters to Demonstrate Safety and Performance of These Devices in a Real-world Setting

EPICADIA - Electrophysiologic Performance Investigation for CArdiac DIAgnosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05314218
Enrollment
168
Registered
2022-04-06
Start date
2022-05-23
Completion date
2023-05-26
Last updated
2023-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrhythmia

Brief summary

The objective of this multicentre study is to collect operative data on the related clinical functional outcomes and complications and of market approved Alcis electrophysiology catheters to demonstrate safety and performance of these devices in a real-world setting.

Detailed description

Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Alcis devices and support peer-reviewed publications on products performance and safety.

Interventions

DEVICEElectrophysiology catheters and cables

The Xtrem electrophysiology catheter was developed for diagnosis of cardiac arrhythmias. Their function is to collect by contact, electrical signals generated by the heart muscle. Xtrem are inserted via femoral vena cava or via artery and can be used in two occasions: * Exploration procedures for diagnosis alone * Diagnosis before ablation procedure An extension cable is used to connect the catheter to a stimulation/ recording device.

Sponsors

Alcis
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

To be included, patients must be: * 18 to 90 years old * Patient who have to undergo diagnostic procedure or ablation procedure (Cardiac arrythmias) * Informed and willing to sign an informed consent for approved by EC * Affiliation to the social security or foreign regime recognized in France

Exclusion criteria

A patient will not be eligible to participate in the study if any of the following conditions are present: * Not able to comply with the study procedures based on the judgment of the assessor (e.g. cannot comprehend study questions, inability to keep scheduled assessment times). * Any medical condition that could impact the study at investigator's discretion (e.g. allergy…). * Pregnant women * Adult subject to legal protection measure

Design outcomes

Primary

MeasureTime frameDescription
Signal qualityThrough study completion, an average of 4 hoursGood signal amplitude and signal stability throughout the procedure without artefact

Secondary

MeasureTime frameDescription
ImagingThrough study completion, an average of 4 hoursVisibility via X ray or 3D navigation.
DiagnosisThrough study completion, an average of 4 hoursDiagnosis efficiency
Micro-stimulationThrough study completion, an average of 4 hoursMicro-stimulation worked well.
ManoeuvrabilityThrough study completion, an average of 4 hoursEase of positioning and manoeuvrability the catheter (access to the desired area)
BendingThrough study completion, an average of 4 hoursLink between the wheel and the bending for dynamic Xtrem and bending stability

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026